Abstract:Objective: To investigate the expression of MEG3 in lung cancer and the role of MEG3 in the invasion and migration of lung cancer cells and its mechanism. Methods: The expression of MEG3 in lung cancer and adjacent lung cancer cells was detected by qPCR. Transwell invasion assay was used to detect the invasion ability of lung cancer cells after silencing MEG3. The migration ability of lung cancer cells after silencing MEG3 was detected by scratch test. The expression of miR-219a was detected by flow cytometry. The expression of miR-219a in lung cancer and adjacent tissues and different lung cancer cells was detected by qPCR. Transwell invasion assay was used to detect the effect of miR-219a on the invasion of lung cancer cells after silencing MEG3. The effect of miR-219a on the tumor size and volume of lung cancer was detected by subcutaneous tumorigenesis of MEG3 in nude mice. The effect of miR-219a on the tumor size and volume of lung cancer cells was detected by scintigraphy. Western blotting was used to detect the expression of Notch pathway protein after silencing MEG3. The morphological changes of microcapsule microtubules after silencing MEG3 were detected by phalloidin staining. Results: The expression of MEG3 was significantly increased in lung cancer tissues compared with adjacent tissues; The expression of MEG3 was the highest in lung cancer cell A549; MEG3 could specifically bind to 3’UTR of miR-219a; The expression of miR-219a was significantly decreased in lung cancer tissues compared with adjacent tissues; Inhibition of miR219a could promote the invasion and migration of lung cancer cells after silencing MEG3; The tumor volume and weight of MEG3-siRNA + miR-219a-inhibitor group were significantly increased compared with MEG3-siRNA group. The expression of Notch pathway protein was down-regulated after silencing MEG3. The number of microfilament microtubules decreased and the number of pseudopods decreased after silencing MEG3. Conclusion: MEG3 plays an important role in the development of lung cancer. MEG3 can regulate the invasion and migration ability of miR219a through Notch signaling pathway.

m6A methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway

LncRNA MEG3-210 Regulates Endometrial Stromal Cells Migration, Invasion and Apoptosis Through P38 MAPK and PKA/SERCA2 Signalling Via Interaction with Galectin-1 in Endometriosis.

LncRNA MEG8 Plays an Oncogenic Role in Hepatocellular Carcinoma Progression Through Mir-367-3p/14-3-3ζ/tgfβr1 Axis.

m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b/BTG2 Signaling

MEG 3 regulates the invasion and migration of lung cancer via targeting miR-219 a and through MAPK pathway

Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer

m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer

Methyltransferase-like 3 Promotes Cervical Cancer Metastasis by Enhancing Cathepsin L Mrna Stability in an N6-methyladenosine-dependent Manner

LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR‐23a/APAF‐1 axis

METTL3-mediated m6A methylation regulates ovarian cancer progression by recruiting myeloid-derived suppressor cells

Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208/SOX4

Long non-coding RNA MEG3 functions as a competing endogenous RNA of miR-93 to regulate bladder cancer progression via PI3K/AKT/mTOR pathway

Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway

HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis

METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway

Downregulated Long Noncoding Rna Meg3 is Associated with Poor Prognosis and Promotes Cell Proliferation in Gastric Cancer

Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis

A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer

Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer

Long non-coding RNA MEG3 acts as a suppressor in breast cancer by regulating miR-330/CNN1

LncRNA CASC15, MiR-23b Cluster and SMAD3 Form a Novel Positive Feedback Loop to Promote Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer